Vorinostat (MK-0683, SAHA [Suberoylanilide Hydroxamic Acid]) + Lenalidomide + Dexamethasone in Multiple Myeloma (MM) (MK-0683-074)
Clinical trial NCT00642954 · COMPLETED
Trial details
- NCT number
- NCT00642954
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-13
- Primary completion
- 2012-09-03
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.